This volume investigates the critical role of biomarkers in advancing herbal drug discovery through a pharmacological lens, focusing on nanotechnological applications for enhanced healthcare. The book explores the emerging field of biomarker-guided herbal medicine, highlighting the advantages of natural compounds over conventional drugs due to their structural diversity and reduced toxicity. It details the identification and therapeutic potential of various phytoconstituents, including terpenoids, fatty acids, flavonoids, and steroids, in managing diverse health conditions. The authors examine how these agents target specific biomarkers such as nitric oxide, cytokines, chemokines, and NF-κβ, offering a comprehensive overview of phytoconstituent-based nanotherapeutics for conditions like arthritis, leishmaniasis, cardiovascular diseases, and cancer.

This book presents a focused exploration of the intersection between biomarkers, herbal medicine, and nanomedicine, likely appealing to researchers and practitioners in pharmacology and alternative medicine. The detailed discussion of specific phytoconstituents and their targeted mechanisms suggests a text aimed at a scientifically literate audience. Its emphasis on novel therapeutic approaches for various diseases positions it as a resource for those seeking to understand the cutting edge of natural product-based drug development.